Lavipharm S.A. Stock price

Equities

LAVI

GRS246003008

Pharmaceuticals

Market Closed - Athens S.E. 11:11:43 2024-03-28 am EDT 5-day change 1st Jan Change
0.886 EUR +0.23% Intraday chart for Lavipharm S.A. -3.70% +11.31%
Sales 2021 39.72M 42.84M Sales 2022 46.01M 49.62M Capitalization 64.46M 69.52M
Net income 2021 1M 1.08M Net income 2022 - 0 EV / Sales 2021 1.64 x
Net Debt 2021 35.69M 38.49M Net Debt 2022 18.93M 20.42M EV / Sales 2022 1.81 x
P/E ratio 2021
17.2 x
P/E ratio 2022
9.91 x
Employees 285
Yield 2021 *
-
Yield 2022
-
Free-Float 32.52%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.68%
1 week-4.36%
Current month-4.57%
1 month-5.59%
3 months+12.28%
6 months+30.65%
Current year+10.30%
More quotes
1 week
0.87
Extreme 0.87
0.94
1 month
0.87
Extreme 0.87
0.95
Current year
0.76
Extreme 0.76
0.96
1 year
0.38
Extreme 0.383
0.96
3 years
0.35
Extreme 0.346
2.22
5 years
0.35
Extreme 0.346
2.22
10 years
0.16
Extreme 0.162
2.22
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 21-11-30
Compliance Officer - -
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member - -
Chairman 84 08-12-31
Director/Board Member - 02-12-31
More insiders
Date Price Change Volume
24-03-28 0.886 +0.23% 132 168
24-03-27 0.884 -0.90% 65,934
24-03-26 0.892 -3.88% 139,029
24-03-22 0.928 +1.09% 143,749
24-03-21 0.918 -0.22% 269,165

Delayed Quote Athens S.E., March 28, 2024 at 07:59 am EDT

More quotes
Lavipharm SA is a Greek commercial and industrial enterprise engaged in the development, manufacture, marketing and distribution of pharmaceutical, cosmetic and over-the-counter (OTC) products. Its main pharmaceutical products cover such categories as anti-inflammatory, asthma controlling, neurological, antiseptic, analgesic, dermatological and gastrointestinal therapies. Its cosmetic products are offered under the brand names of Castalia Soins Dermocosmetiques and Laviderm Active Technology and are used for skin, face and body care, as well as for scalp and hair problems. Its OTC products include cold and flu remedies, oral care, dermatological products, condoms, antiseptics, analgesics, laxatives and gynecology products. It is the parent company of Lavipharm Group of Companies. In January 2014, Robertet SA acquired together with CODIF the HITEX company, specialized in subcontracting of carbon dioxide extraction, from Lavipharm SA.
More about the company
  1. Stock
  2. Equities
  3. Stock Lavipharm S.A. - Athens S.E.